• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Irradiated Hope

Article

Santa Monica, Calif. - With melanoma rates increasing 3 to 5 percent each year, dermatologists can glean some hope from recent study results that found Canvaxin, a therapeutic cancer vaccine, doubled survival rates for patients with advanced melanoma.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.